Clinical Trial Update: Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion [NA]

View source ↗

Summary

A clinical trial evaluating a tailored re-ablation strategy targeting EGM dispersion for atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Volta Medical | Conditions: Atrial Fibrillation | NA | Status: COMPLETED